Cite
HARVARD Citation
Cadoo, K. et al. (n.d.). 2765 Re-treating with carboplatin and paclitaxel as first line therapy for recurrent endometrial cancer in patients who have previously received this regimen in the adjuvant setting. European journal of cancer. pp. S552-. [Online].